Sumitomo Shuji

スミトモシュウジ | Sumitomo Shuji

Affiliation and department：
Job title：医長
Homepage URL (1)： http://kaken.nii.ac.jp/d/r/20392996.ja.html

Research field (1)： Allergies and connective tissue disease

Research keywords (5)：免疫学 , ゲノム , 生体分子 , 細胞・組織 , 内科

Research theme for competitive and other funds (8)：

2020 - 2023 ベーチェット病におけるHLA-B51とCD8陽性T細胞の関連についての検討
2019 - 2022 Elucidation of pathogenesis of autoimmune-mediated interstitial lung disease based on epigenomic analysis
2017 - 2020 Analysis of signaling pathways identified by transcriptome analysis of rheumatoid arthritis samples
2016 - 2019 Cytokine synergy-mediated control of humoral immune tolerance
2017 - 2019 関節リウマチ検体のトランスクリプトーム解析で同定された新規シグナルの検討

Show all

Papers (71)：

Hideki Oka, Shuji Sumitomo, Hayato Shimizu, Koichiro Ohmura. Markedly elevated serum IL-6 levels predict relapse within six months of treatment initiation in Still's disease. Clinical and experimental rheumatology. 2024
Hirokazu Taguchi, Shuji Sumitomo, Hideki Oka, Shigeo Hara, Koichiro Ohmura. Löfgren syndrome, characteristics of Japanese cases: a case and a review of the literature. Modern rheumatology case reports. 2024
Haruka Tsuchiya, Mineto Ota, Haruka Takahashi, Hiroaki Hatano, Megumi Ogawa, Sotaro Nakajima, Risa Yoshihara, Tomohisa Okamura, Shuji Sumitomo, Keishi Fujio. Epigenetic targets of Janus kinase inhibitors are linked to genetic risks of rheumatoid arthritis. Inflammation and regeneration. 2024. 44. 1. 29-29
Yoichi Nakayama, Wataru Nagata, Yoichi Takeuchi, Sho Fukui, Yuya Fujita, Yohei Hosokawa, Masanobu Ueno, Kumiko Ono, Shuji Sumitomo, Yuya Tabuchi, et al. Systematic review and meta-analysis for the 2024 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis. Modern rheumatology. 2024
Shion Kachi, Shuji Sumitomo, Hideki Oka, Akito Hata, Koichiro Ohmura. Case report: Inflammatory sternoclavicular joint arthritis induced by an immune checkpoint inhibitor with remarkable responsiveness to infliximab. Frontiers in immunology. 2024. 15. 1400097-1400097

ｍore...

MISC (312)：

住友秀次, 大村浩一郎. Rituximab. 腎と透析. 2023. 94. 6
住友秀次. ここが変わった!関節リウマチの治療リウマチ患者さんの「困った!」「大丈夫?」に対処する 9)痛みやこわばりを軽減する方法は?. 薬局. 2023. 74. 3
住友秀次, 岡秀樹, 岡秀樹, 志水隼人, 志水隼人, 金森真紀, 西岡弘晶, 大村浩一郎. ANCA関連血管炎におけるびまん性肺胞出血に関する要因の検討. 日本リウマチ学会総会・学術集会プログラム・抄録集. 2023. 67th
住友秀次. Functional status assessment measures in rheumatoid arthritis. 月刊リウマチ科. 2023. 70. 2
岡秀樹, 岡秀樹, 住友秀次, 志水隼人, 志水隼人, 金森真紀, 西岡弘晶, 大村浩一郎. 全身性エリテマトーデスの持続するDORIS寛解,LLDASの非達成因子の検討. 日本リウマチ学会総会・学術集会プログラム・抄録集. 2023. 67th

ｍore...

Education (3)：

2005 - 2009 東京大学大学院医学系研究科内科学専攻博士課程
1997 - 2001 The University of Tokyo Faculty of Medicine School of Medicine
1995 - 1997 The University of Tokyo College of Arts and Sciences

Professional career (1)：

医学博士 (東京大学)

Work history (9)：

2021/04 - 現在 Kobe City Medical Center General Hospital Department of Rheumatology
2020/04 - 2021/03 Kobe City Medical Center General Hospital
2020/01 - 2020/03 The University of Tokyo Faculty of Medicine University Hospital, Allergy and Rheumatology
2017/09 - 2020/01 The University of Tokyo Faculty of Medicine University Hospital, Allergy and Rheumatology
2011/06 - 2017/09 The University of Tokyo Faculty of Medicine University Hospital, Allergy and Rheumatology

Show all

Committee career (8)：

2018/01 - 現在日本臨床免疫学会免疫療法認定医
2017/04 - 現在日本リウマチ学会評議員
2016/03 - 現在日本リウマチ学会指導医
2016/03 - 現在日本リウマチ学会登録ソノグラファー
2016/01 - 現在日本臨床免疫学会評議員

Show all

Association Membership(s) (6)：

THE JAPANESE SOCIETY OF INFLAMMATION AND REGENERATION , THE JAPAN SOCIETY FOR CLINICAL IMMUNOLOGY , THE JAPANESE SOCIETY FOR IMMUNOLOGY , THE JAPANESE SOCIETY OF INTERNAL MEDICINE , JAPANESE SOCIETY OF ALLERGOLOGY , JAPAN COLLEGE OF RHEUMATOLOGY

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page